Trial Profile
Multicentre clinical trial to evaluate the analgesic efficacy and safety of Dexketoprofen [dexketoprofen trometamol] (50 mg t.i.d.) vs. Ketorolac (30 mg t.i.d.) by intravenous route as part of balanced analgesic therapy with morphine followed by oral dose administration in postoperative pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Apr 2022
Price :
$35
*
At a glance
- Drugs Dexketoprofen (Primary) ; Dexketoprofen (Primary) ; Ketorolac; Ketorolac
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Menarini
- 08 Apr 2022 Status changed from recruiting to completed.
- 13 Mar 2008 New trial record.